Skip to main content
. Author manuscript; available in PMC: 2016 Jun 9.
Published in final edited form as: Am J Cardiol. 2013 Oct 4;113(2):321–327. doi: 10.1016/j.amjcard.2013.08.047

Table 1.

Baseline clinical characteristics and placebo-corrected changes in peak VO2

Age (yrs) Gender Ethnicity Hypertension Diabetes NYHA Class BNP hs-CRP LVEF LVEDVi LVMi E/E′ LVEDP Peak VO2 VE/VCO2 OUES Change in peak VO2
#1 40 F C Y N 2 43 4.7 63 33 72 24 n/a 16.9 24.6 2.08 +1.9
#2 52 F AA Y N 2 8 9.9 63 43 131 8 n/a 20.5 23.2 2.21 −1.1
#3 55 F AA Y Y 3 39 3.5 57 59 123 11 18 16.2 30.6 1.79 +1.7
#4 55 F AA Y N 2 19 6.6 58 33 91 11 n/a 18.7 22.3 2.85 −1.0
#5 57 F AA Y Y 2 2 17.0 57 41 79 11 17 14.1 25.2 2.12 +3.0
#6 60 F AA Y Y 3 25 11.5 60 62 125 15 n/a 13.8 24.9 1.92 −0.7
#7 62 F C Y Y 3 39 5.0 64 37 68 11 34 16.1 29.6 2.54 +2.1
#8 63 F AA Y N 2 11 15.2 74 34 89 21 20 14.4 22.2 1.8 +0.4
#9 64 F C Y Y 3 112 2.6 53 40 78 10 n/a 13.1 33 1.34 +1.7
#10 64 F AA Y Y 3 131 15.5 67 41 90 20 n/a 11.4 21.1 2.02 +3.5
#11 65 M C Y Y 2 23 3.1 59 60 68 11 n/a 17.3 31.1 1.73 +3.0
#12 70 F AA Y N 3 414 18.2 51 78 100 19 15 9.4 45.4 1.22 +1.8

Abbreviations: AA=African-American; BNP=Brain natriuretic peptide (pg/ml) ; C=Caucasian; E/E′= ratio of transmitral Doppler early filling velocity to tissue Doppler early diastolic mitral annular velocity; F=female; hs-CRP=high sensitivity C-reactive protein (mg/l); LVEDVi=left ventricular end-diastolic volumeindex (ml/m2); LVEF=left ventricular ejection fraction (%); LV Mass index=left ventricular mass index (g/m2); M=male; N=no; n/a=not available; NYHA Class=New York Heart Association functional classification system for heart failure; OUES= Oxygen-uptake efficiency slope; Peak VO2=maximal oxygen consumption during cardiopulmonary exercise testing (ml•kg−1•min−1); VE/VCO2=ventilatory equivalent ratio for carbon dioxide; Y=yes.